Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors.

ABSTRACT: Previous work established a coumarin scaffold as a starting point for inhibition of Mycobacterium tuberculosis (Mtb) FadD32 enzymatic activity. After further profiling of the coumarin inhibitor 4 revealed chemical instability, we discovered that a quinoline ring circumvented this instability and had the advantage of offering additional substitution vectors to further optimize. Ensuing SAR studies gave rise to quinoline-2-carboxamides with potent anti-tubercular activity. Further optimization of ADME/PK properties culminated in 21b that exhibited compelling in vivo efficacy in a mouse model of Mtb infection.

SUBMITTER: Fang C 

PROVIDER: S-EPMC6233306 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature